Abstract
Biotechnology mergers and acquisitions are gaining momentum, but may not always lead to a financial windfall.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
McCafferty, J. April 1998. CFO 44–52.
Persidis, A. 1998. Nat. Biotechnol. 16: 981– 983.
Hamilton, J.O.C. 1998. Recombinant Capital. http://www.recap.com.
James, B.G. 1998. Decision Resources, PharmVision 2005.
Champsi, F.H. 1998. Nat. Biotechnol. (Bioentrepre-neurship Suppl.)16: 61–62.
Esposito, R.S. and Ostro, M.J. 1998. Nat. Biotechnol. (Bioentrepreneurship Suppl.) 16: 63.
Bernstein K. et al.1998.BioCentury 6/54: A1–A6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Persidis, A. Consolidations in biotechnology. Nat Biotechnol 17 (Suppl 1), BE3–BE4 (1999). https://doi.org/10.1038/4624
Issue date:
DOI: https://doi.org/10.1038/4624